In recent years, the application of artificial intelligence (AI) in healthcare has rapidly evolved, encompassing tasks from analyzing radiology scans to managing patient interactions and claims processing. However, the lack of comprehensive regulatory guidance presents significant challenges for healthcare systems and AI developers in determining the appropriate tools to implement and ensuring their safe use. Currently, the FDA’s regulatory oversight covers only a limited scope of these applications, leaving many stakeholders uncertain about best practices.
In response to this regulatory void, several organizations, ranging from emerging collectives to established trade groups, are stepping forward to provide much-needed guidance. Their efforts aim to unify industry standards, which could lead to a more structured approach to evaluating and monitoring health AI technologies. By fostering widespread adoption, these groups could influence the development of future regulations and help mitigate risks that may adversely affect patients and the healthcare sector.
Continue to STAT+ to read the full story…
Get started today with Solo access →
